← Unusual insider activity · Company hub
EW Edwards Lifesciences Corp
Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.
-$4.6M net selling - trailing 90 days
0 buyers - 7 unique sellers
Historical context: most recent complete month (2026-08) is the 15th percentile of this ticker's monthly net P/S flow over 23 complete months (limited history). Lower percentiles are more selling; higher are more buying.
6 accumulating - 6 trimming - 1 unchanged
13 comparable institutions - Q2 2026
open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.
Who is responsible
| Insider | Role | Net activity | Rows |
|---|---|---|---|
| Chopra Daveen | CVP, TMTT, Surgical & IHFM | -~$2.9M | 2 |
| Markowitz Wayne | CVP, JAPAC | -~$0.9M | 3 |
| Zovighian Bernard J | CEO | -~$0.2M | 1 |
| Bruls Annette | CVP, EMEACLA | -~$0.2M | 1 |
| Lippis Daniel J. | CVP, TAVR | -~$0.2M | 3 |
| Lippis Daniel J. | CVP, TAVR | -~$54K | 1 |
| Dahl Andrew M. | SVP, Corporate Controller | -~$50K | 1 |
Transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 9/11/2026 | Lippis Daniel J. | CVP, TAVR | S | -619 | 87.51 | ~$54K |
| 8/31/2026 | Dahl Andrew M. | SVP, Corporate Controller | S | -544 | 91.055 | ~$50K |
| 8/28/2026 | Bruls Annette | CVP, EMEACLA | S | -2644 | 89.98 | ~$0.2M |
| 8/26/2026 | Markowitz Wayne | CVP, JAPAC | S | -1240 | 91.465 | ~$0.1M |
| 8/26/2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | 2 reported sale rows | 31800 | — | ~$2.9M |
| 8/26/2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | S | -1154 | 91.7614 | ~$0.1M |
| 8/26/2026 | Chopra Daveen | CVP, TMTT, Surgical & IHFM | S | -30646 | 90.9922 | ~$2.8M |
| 8/11/2026 | Lippis Daniel J. | CVP, TAVR | S | -619 | 92.03 | ~$57K |
| 7/30/2026 | Markowitz Wayne | CVP, JAPAC | S | -146.3127 | 86.0338 | ~$13K |
| 7/28/2026 | Markowitz Wayne | CVP, JAPAC | S | -9628 | 85.06 | ~$0.8M |
| 7/27/2026 | Zovighian Bernard J | CEO | S | -2920.5511 | 83.9342 | ~$0.2M |
| 7/10/2026 | Lippis Daniel J. | CVP, TAVR | S | -619 | 91.7 | ~$57K |
| 6/30/2026 | Lippis Daniel J. | CVP, TAVR | S | -619 | 91.4002 | ~$57K |
| 6/17/2026 | Zovighian Bernard J | CEO | S | -523 | 87.92 | ~$46K |
| 5/29/2026 | Dahl Andrew M. | SVP, Corporate Controller | S | -567.5266 | 86.08 | ~$49K |
| 5/27/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -23145 | 86.4201 | ~$2.0M |
| 5/22/2026 | Chopra Daveen | CVP, TMTT & Surgical | S | -1500 | 84.6035 | ~$0.1M |
| 5/18/2026 | Lippis Daniel J. | CVP, TAVR | S | -620 | 81.14 | ~$50K |
| 5/15/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | 2 reported sale rows | 17968 | — | ~$1.5M |
| 5/15/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -9968 | 82.0732 | ~$0.8M |
| 5/15/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -8000 | 81.8216 | ~$0.7M |
| 5/12/2026 | Zovighian Bernard J | CEO | 2 reported sale rows | 36351 | — | ~$2.8M |
| 5/12/2026 | Zovighian Bernard J | CEO | S | -35506 | 77.9238 | ~$2.8M |
| 5/12/2026 | Zovighian Bernard J | CEO | S | -845 | 78.4027 | ~$66K |
| 5/11/2026 | Markowitz Wayne | CVP, JAPAC | S | -593 | 79.73 | ~$47K |
| 5/4/2026 | Lippis Daniel J. | CVP, TAVR | S | -1019 | 83.98 | ~$86K |
| 5/1/2026 | Lippis Daniel J. | CVP, TAVR | 2 reported sale rows | 1019 | — | ~$85K |
| 5/1/2026 | Lippis Daniel J. | CVP, TAVR | S | -1000 | 82.9889 | ~$83K |
| 5/1/2026 | Lippis Daniel J. | CVP, TAVR | S | -19 | 83.988 | ~$2K |
| 4/9/2026 | Ullem Scott B. | CVP, Chief Financial Officer | 2 reported sale rows | 13000 | — | ~$1.0M |
| 4/9/2026 | Ullem Scott B. | CVP, Chief Financial Officer | S | -4676 | 80.4963 | ~$0.4M |
| 4/9/2026 | Ullem Scott B. | CVP, Chief Financial Officer | S | -8324 | 79.7866 | ~$0.7M |
| 4/6/2026 | Lippis Daniel J. | CVP, TAVR | S | -1019 | 80.984 | ~$83K |
| 4/2/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | 2 reported sale rows | 22680 | — | ~$1.8M |
| 4/2/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -18004 | 80.0494 | ~$1.4M |
| 4/2/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -4676 | 80.5915 | ~$0.4M |
| 3/11/2026 | Ullem Scott B. | CVP, Chief Financial Officer | 2 reported sale rows | 13000 | — | ~$1.1M |
| 3/11/2026 | Ullem Scott B. | CVP, Chief Financial Officer | S | -7901 | 85.2079 | ~$0.7M |
| 3/11/2026 | Ullem Scott B. | CVP, Chief Financial Officer | S | -5099 | 84.4613 | ~$0.4M |
| 3/11/2026 | Lippis Daniel J. | CVP, TAVR | S | -1019 | 85.3822 | ~$87K |
| 3/2/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -11340 | 85.9286 | ~$1.0M |
| 2/25/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -24000 | 83.8365 | ~$2.0M |
| 2/12/2026 | Zovighian Bernard J | CEO | 2 reported sale rows | 22430 | — | ~$1.7M |
| 2/12/2026 | Zovighian Bernard J | CEO | S | -19898 | 76.6133 | ~$1.5M |
| 2/12/2026 | Zovighian Bernard J | CEO | S | -2532 | 77.1287 | ~$0.2M |
| 1/9/2026 | Lippis Daniel J. | CVP, TAVR | S | -1019 | 85.7037 | ~$87K |
| 1/6/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | 2 reported sale rows | 11340 | — | ~$1.0M |
| 1/6/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -2632 | 84.6206 | ~$0.2M |
| 1/6/2026 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -8708 | 85.9793 | ~$0.7M |
| 12/12/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | 2 reported sale rows | 11386.1175 | — | ~$1.0M |
| 12/12/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -5900 | 83.74 | ~$0.5M |
| 12/12/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -5486.1175 | 83.79 | ~$0.5M |
| 12/12/2025 | STONE HEISZ LESLIE | — | S | -2615 | 83.4109 | ~$0.2M |
| 12/12/2025 | Lippis Daniel J. | CVP, JAPAC | S | -1019 | 84.0287 | ~$86K |
| 12/11/2025 | Chopra Daveen | CVP, TMTT & Surgical | S | -2000 | 84.3751 | ~$0.2M |
| 12/10/2025 | Zovighian Bernard J | CEO | S | -3863 | 83.45 | ~$0.3M |
| 12/10/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -11340 | 83.8255 | ~$1.0M |
| 12/9/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -7700 | 84.4691 | ~$0.7M |
| 12/8/2025 | Zovighian Bernard J | CEO | S | -21487 | 85.2146 | ~$1.8M |
| 12/8/2025 | Markowitz Wayne | CVP, JAPAC | S | -583 | 86.01 | ~$50K |
| 11/10/2025 | Ullem Scott B. | CVP, Chief Financial Officer | 2 reported sale rows | 13000 | — | ~$1.1M |
| 11/10/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -10026 | 83.0201 | ~$0.8M |
| 11/10/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -2974 | 83.2999 | ~$0.2M |
| 11/10/2025 | Lippis Daniel J. | CVP, JAPAC | S | -1020 | 82.5451 | ~$84K |
| 8/25/2025 | Chopra Daveen | CVP, TMTT | S | -2500 | 81.946 | ~$0.2M |
| 8/18/2025 | Wood Larry L | Global President TAVR & Surg | S | -8950 | 78.0647 | ~$0.7M |
| 7/28/2025 | Lippis Daniel J. | CVP, JAPAC | S | -4114 | 79.4605 | ~$0.3M |
| 6/16/2025 | Wood Larry L | Global President TAVR & Surg | S | -8950 | 75.2255 | ~$0.7M |
| 6/3/2025 | Zovighian Bernard J | CEO | S | -967 | 77.3232 | ~$75K |
| 6/2/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -2570 | 77.3974 | ~$0.2M |
| 5/30/2025 | Zovighian Bernard J | CEO | S | -16099 | 77.2138 | ~$1.2M |
| 5/22/2025 | Chopra Daveen | CVP, TMTT | S | -1500 | 75.075 | ~$0.1M |
| 5/9/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -11250 | 74.4031 | ~$0.8M |
| 5/9/2025 | Lippis Daniel J. | CVP, JAPAC | S | -330 | 74.4232 | ~$25K |
| 5/7/2025 | Markowitz Wayne | GM & SVP, Surgical | S | -268 | 75.0778 | ~$20K |
| 5/5/2025 | Zovighian Bernard J | CEO | S | -5980 | 74.9125 | ~$0.4M |
| 4/14/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -9500 | 69.8101 | ~$0.7M |
| 4/8/2025 | Lippis Daniel J. | CVP, JAPAC | S | -300 | 70.61 | ~$21K |
| 3/26/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -11250 | 70.8682 | ~$0.8M |
| 3/13/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -9500 | 67.9604 | ~$0.6M |
| 3/10/2025 | Zovighian Bernard J | CEO | S | -6164 | 69.5081 | ~$0.4M |
| 3/10/2025 | Lippis Daniel J. | CVP, JAPAC | S | -400 | 69.48 | ~$28K |
| 2/28/2025 | Ullem Scott B. | CVP, Chief Financial Officer | 2 reported sale rows | 11250 | — | ~$0.8M |
| 2/28/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -3490 | 71.3819 | ~$0.2M |
| 2/28/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -7760 | 70.516 | ~$0.5M |
| 2/14/2025 | LORANGER STEVEN R | — | S | -5739 | 76.4202 | ~$0.4M |
| 2/13/2025 | STONE HEISZ LESLIE | — | S | -5739 | 75.8618 | ~$0.4M |
| 2/13/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | 2 reported sale rows | 6500 | — | ~$0.5M |
| 2/13/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -6400 | 75.7402 | ~$0.5M |
| 2/13/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -100 | 76.26 | ~$8K |
| 2/13/2025 | Ullem Scott B. | CVP, Chief Financial Officer | S | -11250 | 75.7575 | ~$0.9M |
| 2/13/2025 | Lippis Daniel J. | CVP, JAPAC | S | -500 | 76.34 | ~$38K |
| 1/16/2025 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -5000 | 68.7471 | ~$0.3M |
| 1/16/2025 | Lippis Daniel J. | CVP, JAPAC | S | -500 | 68.7643 | ~$34K |
| 12/16/2024 | Lippis Daniel J. | CVP, JAPAC | S | -2500 | 74.0783 | ~$0.2M |
| 12/9/2024 | Ullem Scott B. | CVP, Chief Financial Officer | S | -11250 | 71.6805 | ~$0.8M |
| 12/9/2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -5000 | 71.7501 | ~$0.4M |
| 12/6/2024 | Chopra Daveen | CVP, TMTT | S | -1750 | 73.2701 | ~$0.1M |
| 12/6/2024 | Markowitz Wayne | GM & SVP, Surgical | S | -583 | 73.27 | ~$43K |
| 11/13/2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -5000 | 65.5686 | ~$0.3M |
| 11/5/2024 | Wood Larry L | Global President TAVR & Surg | S | -25000 | 65.9145 | ~$1.6M |
| 10/15/2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -5000 | 69.5067 | ~$0.3M |
| 9/11/2024 | BOBO DONALD E JR | CVP,Strategy/Corp Development | S | -5000 | 66.7651 | ~$0.3M |